Earlier Merck Study Indicated Risks of Vioxx
613250
Nearly one year ago, Merck received preliminary results from a study of patient records that apparently indicated Vioxx posed cardiovascular risks.
216989
Merck &amp; Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
611376
(Ivanhoe Newswire) -- A new study reveals a greater risk of heart attack associated with Vioxx (rofecoxib) than with Celebrex (celecoxib), although neither drug shows a statistically significant elevated risk of heart attack relative to people who did not
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
647611
A study out Tuesday found that Vioxx users were nearly three times more likely to suffer a heart attack than people taking Celebrex, a similar pain reliever.
538874
An independent study carried out at the University of Pennsylvania has shown that your risk of having a heart attack is three times greater with Vioxx than with Celebrex.
152957
Professor Garret A FitzGerald, an eminent cardiologists, University of Pennsylvania School of Medicine, says doctors should be cautious about using Vioxx type medicines, especially if the patient is at risk of heart disease.
66432
TRENTON, NJ -- Merck &amp; Co. withdrew best-selling arthritis drug Vioxx on Thursday after a study showed the drug doubled the risk of heart attacks and strokes.
541938
Merck & Co. faces a dual threat from health insurers and patients' lawyers, after a U.S. study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
373977
Two studies released yesterday have turned up new evidence that all of the popular arthritis painkillers known as cox-2 inhibitors may put users at greater risk of heart attacks and strokes.
219397
NEW YORK (CBS.MW) -- Merck (MRK) is out with a statement that &quot;strongly disagrees&quot; with the findings of a new study that raised questions about the safety of its Vioxx arthritis drug.
323949
Pharmaceutical giant Merck &amp; Co Inc. had evidence by 2000 that its painkiller Vioxx, which was pulled off the market on Sept. 30, was not safe, a heart specialist told CBS News program &quot;60 Minutes&quot; on Sunday.
11707
Patients taking Merck & Co. Inc.'s Vioxx arthritis drug had a 50 percent greater chance of heart attacks and sudden cardiac death than individuals using Pfizer Inc.'s rival Celebrex medicine, according to a large study financed by the U.S. Food and Drug Administration.
538184
A study in a leading medical journal found Pfizer&#39;s Celebrex does not pose the same risk of causing heart attacks as Vioxx, the competing medicine Merck withdrew from the market because of safety concerns.
519656
A lawyer who represents Merck & Co. in its litigation over Vioxx said on Tuesday that an unpublished study that reportedly shows heart risks with the withdrawn painkiller in short-term use is not supported by other data.
54004
Pharmaceutical giant Merck & Co Inc.  had evidence by 2000 that its painkiller Vioxx, which was  pulled off the market on Sept. 30, was not safe, a heart  specialist told CBS News program "60 Minutes" on Sunday.
28228
US drugs giant Merck &amp; Co Inc. should have pulled its Vioxx painkiller from the market four years ago, because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.